Vimarsana
Biggest News Aggregation in the World

Anna Gottschlich News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anna Gottschlich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anna Gottschlich Today - Breaking & Trending Today

Primary HPV Screening Intervals Could Be Extended - Vimarsana News

Primary HPV Screening Intervals Could Be Extended

HPV testing eight years after negative result was comparable to risk after three years in cytology cohort

Source: empr.com
Data show longer intervals between HPV testing likely safe - Vimarsana News

Data show longer intervals between HPV testing likely safe

A 5-year interval between cervical cancer screenings using HPV testing does not increase risk for cervical precancer detection compared with cytology every 3 years and may be a more effective screening method long term, researchers report.The U.S. has gradually transitioned from cytology to HPV-based screening for cervical cancer over the past 20 years, according to Anna Gottschlich, PhD, MPH,

Source: healio.com
Study: 8-year interval between HPV tests for cervical cancer may be safe, effective - Vimarsana News

Study: 8-year interval between HPV tests for cervical cancer may be safe, effective

HPV testing to prevent cervical cancer might not have to happen as often as currently recommended, a new study says.

Source: upi.com
HPV testing for cervical cancer may be safe at longer intervals than what current guidelines recommend - Vimarsana News

HPV testing for cervical cancer may be safe at longer intervals than what current guidelines recommend

Over the past two decades, the United States has been transitioning from cytology to HPV-based screening for cervical cancer. The U.S. Preventive Services Task Force currently recommends one of three options for routine cervical cancer screening: 1) cytology screening every three years; 2) HPV screening every five years; or 3) co-testing in which both an HPV and cytology screening are conducted every five years.